Brain Leukocytes as the Potential Therapeutic Target for Post-COVID-19 Brain Fog
Description
After recovering from the acute phase of coronavirus disease 2019 (COVID-19), many patients struggle with additional symptoms of long COVID during the chronic phase. Among them, the neuropsychiatric manifestations characterized by a short-term memory
